437 related articles for article (PubMed ID: 16484294)
1. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
[TBL] [Abstract][Full Text] [Related]
3. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.
Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E781-9. PubMed ID: 15166001
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6.
Jain SS; Chabowski A; Snook LA; Schwenk RW; Glatz JF; Luiken JJ; Bonen A
FEBS Lett; 2009 Jul; 583(13):2294-300. PubMed ID: 19527715
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
[TBL] [Abstract][Full Text] [Related]
6. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered.
Koonen DP; Benton CR; Arumugam Y; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E1042-9. PubMed ID: 15140757
[TBL] [Abstract][Full Text] [Related]
8. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR.
Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
FEBS Lett; 2005 Apr; 579(11):2428-32. PubMed ID: 15848183
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
[TBL] [Abstract][Full Text] [Related]
10. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle.
Luiken JJ; Glatz JF; Bonen A
Can J Appl Physiol; 2000 Oct; 25(5):333-52. PubMed ID: 11073569
[TBL] [Abstract][Full Text] [Related]
12. Regulation of fatty acid transport by fatty acid translocase/CD36.
Bonen A; Campbell SE; Benton CR; Chabowski A; Coort SL; Han XX; Koonen DP; Glatz JF; Luiken JJ
Proc Nutr Soc; 2004 May; 63(2):245-9. PubMed ID: 15294038
[TBL] [Abstract][Full Text] [Related]
13. Effects of AMPK activators on the sub-cellular distribution of fatty acid transporters CD36 and FABPpm.
van Oort MM; van Doorn JM; Hasnaoui ME; Glatz JF; Bonen A; van der Horst DJ; Rodenburg KW; P Luiken JJ
Arch Physiol Biochem; 2009 Jul; 115(3):137-46. PubMed ID: 19480562
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific and fatty acid transporter-specific changes in heart and soleus muscle over a 1-yr period.
Bonen A; Nickerson JG; Momken I; Chabowski A; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ
Mol Cell Biochem; 2006 Oct; 291(1-2):145-54. PubMed ID: 16718359
[TBL] [Abstract][Full Text] [Related]
15. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
[TBL] [Abstract][Full Text] [Related]
16. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
[TBL] [Abstract][Full Text] [Related]
17. Not only accumulation, but also saturation status of intramuscular lipids is significantly affected by PPARγ activation.
Chabowski A; Zendzian-Piotrowska M; Nawrocki A; Górski J
Acta Physiol (Oxf); 2012 May; 205(1):145-58. PubMed ID: 22023892
[TBL] [Abstract][Full Text] [Related]
18. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
19. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
20. PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents.
Lanne B; Dahllöf B; Lindahl C; Ebefors K; Kanmert I; von Bahr H; Miliotis T; Nyström AC; Arnerup G; Paulsons I; Kerb S; Oakes N
J Proteome Res; 2006 Aug; 5(8):1850-9. PubMed ID: 16889406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
